尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Joshi Manher. Insider active across 2 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €9k. Activity tracked since 16 August 2023. The latest transaction was disclosed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Joshi Manher is a declarant linked to Soleno Therapeutics INC, where he is Chief Development Officer, and to Atara Biotherapeutics, Inc., where he is EVP, Chief Medical Officer. The 4 filings recorded cover the period from 2023-08-18 to 2026-01-23, and within this recent sample, sales total EUR 9267 and purchases EUR 0.